Thus, as in the developing CNS [9] Sox3 has the capacity to maintain glioma cells in an undifferentiated and proliferating state, whereas active repression of Sox3 target genes causes cells to exit the cell cycle. The gene discussed is SOX3; the disease is central nervous system cancer.